MYCN and neoplasm: Consistent with the viability‐based IC50 values, the dose of ceftriaxone used to inhibit 50% colony formation of MYCN‐amplified tumor cells was lower than that used in MYCN‐nonamplified tumor cells, confirming growth inhibition of MYCN‐driven tumors upon ceftriaxone treatment (Fig. 1K,L).